Yeah, it's a little confusing. I'm with you @SaltyInvestor.
But the AFR seems to like it, annoucing "CSL increases dividend, flags profit growth in FY21".
When I look at the current years results, they have missed NPAT guidance by $7 million ($2,103M) but on a constant currency basis, the NPAT is $2,247M.
The outlook for FY2021 is a range. It could be flat, but it could be up by as much as 8%. This factors in new costs of R&D for a COVID vaccine and 4 COVID treatments, as well as global economic uncertainty.
Really, an extremely good result for 2020, and going forward for 2021, given we are in the depths of a global pandemic and the worst global recession since the Great Depression.
Ann: CSL Results Announcement, page-17
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$308.93 |
Change
0.400(0.13%) |
Mkt cap ! $149.2B | |||
| Open | High | Low | Value | Volume |
| $310.56 | $311.00 | $308.84 | $113.8M | 367.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 150 | $308.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $308.94 | 120 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |